With lots of ASX shares to choose from on the Australian market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are outlined below. Let's see why they are bullish on them.
According to a note out of Citi, its analysts have retained their buy rating and $39.85 price target on this appliance manufacturer's shares. The broker highlights that one of Breville's rivals has released a quarterly update which it believes has positive takeaways. It points out that the update revealed that the coffee market has remained strong in the Americas, which bodes well for Breville. In fact, despite the tough economic environment, Citi points out that the rival's growth rate has strengthened since the release of its previous quarterly update. In light of this, the broker appears confident that Breville will deliver on expectations and sees value in its shares at current levels. The Breville share price last traded at $33.82.
A note out of UBS reveals that its analysts have retained its buy rating and $158.00 price target on this biotechnology giant's shares. The broker has also been looking at a rival's recent update and believes it points to robust demand in the immunoglobulin market. And while CSL's performance has been disappointing this year, UBS believes that it will pick up in FY 2027 and is expecting the company to win back market share from rivals. Another positive is that it is seeing early signs of a recovery in the albumin market. The CSL share price was fetching $128.83 at yesterday's close.
Analysts at Macquarie have retained their outperform rating on this location technology company's shares with a trimmed price target of $31.10. According to the note, the broker believes that recent hiring activity suggests that Life360 is building out its advertising business. This could support strong revenue growth from this side of the business in FY 2027. In addition, Macquarie believes that the recent launch of an Apple Watch app from Life360 could be supportive of subscription growth in the second half of the year. The Life360 share price last traded at $28.47.
The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in CSL and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Life360, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026